Clinical Trials Sponsored by In8bio Inc.

Total 35448 results

In8bio Inc.

Recruiting

A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma

Glioblastoma

United States
University of Alabama at Birmingham
In8bio Inc.

Active, not recruiting

Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma (DRI)

Brain Tumor Adult

United States
University of Kansas Medical Center
In8bio Inc.

Recruiting

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia

United States
InBios International, Inc.

Completed

Sensitivity Study of Diagnostic for Early Detection of Dengue Infection

Infectious Diseases

Argentina, Barbados, Colombia, Sri Lanka, Thailand
InBios International, Inc.

Completed

Specificity Study of Diagnostic for Early Detection of Dengue Infection

Infectious Diseases

United States
InBios International, Inc.

Completed

Specificity Study of Diagnostic for Chagas Disease

Infectious Diseases

United States
InBios International, Inc.

Completed

Sensitivity Study of Diagnostic for Detection of Chagas Infection

Infectious Diseases

Bolivia, Chile
GeneOne Life Science, Inc.
Inovio Pharmaceuticals

Completed

Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males

Healthy

Korea, Republic of
Invibio Ltd
Medical Metrics Diagnostics, Inc

Completed

A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced Interbody Cages in the Lumbar Spine

Spondylolisthesis, Grade 1 | Degenerative Disc Disease Lumbar

United States
GeneOne Life Science, Inc.
Inovio Pharmaceuticals

Completed

GLS-5700 in Dengue Virus Seropositive Adults

Healthy | Zika

Puerto Rico
GeneOne Life Science, Inc.
Inovio Pharmaceuticals

Completed

GLS-5700 in Healthy Volunteers

Healthy

United States, Canada
GeneOne Life Science, Inc.
Inovio Pharmaceuticals

Completed

Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection

HCV Infection

Korea, Republic of
GeneOne Life Science, Inc.
Inovio Pharmaceuticals

Completed

Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection (VGX-6150-01)

Hepatitis C, Chronic

Korea, Republic of
Inovio Pharmaceuticals

Completed

INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)

Respiratory Papillomatosis

United States
Inovio Pharmaceuticals

Completed

REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) (REVEAL 1)

Cervical Dysplasia | Cervical High Grade Squamous Intraepithelial Lesion | HSIL

United States, Spain, Portugal, Italy, Philippines, Thailand, Slovakia, Lithuania, Estonia, Belgium, South Africa, Germany, Argentina, United Kingdom, Poland, Puerto Rico, Finland, Mexico, Peru
Inovio Pharmaceuticals

Active, not recruiting

INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

Urothelial Carcinoma

United States, Spain
Inovio Pharmaceuticals

Active, not recruiting

INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)

Glioblastoma

United States
Inovio Pharmaceuticals

Withdrawn

Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers

Coronavirus Infection
Inovio Pharmaceuticals

Completed

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Cervical Dysplasia | Cervical High Grade Squamous Intraepithelial Lesion | HSIL

United States, Spain, Lithuania, Estonia, South Africa, Argentina, Brazil, Finland, Poland, Puerto Rico
Inovio Pharmaceuticals

Completed

Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3

Papillomavirus Infections

United States, Puerto Rico
Inovio Pharmaceuticals

Completed

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Human Papillomavirus (HPV) | Vulvar Dysplasia | Vulvar Intraepithelial Neoplasia (VIN) | Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) | VIN2 | VIN3 | Pre-cancerous Lesions of the Vulva

United States
Inovio Pharmaceuticals

Completed

A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer

Cervical Cancer

United States
Inovio Pharmaceuticals

Completed

Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100

Human Papillomavirus (HPV)

Puerto Rico, United States
Inovio Pharmaceuticals

Completed

Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer

Head and Neck Cancer

United States
Inovio Pharmaceuticals

Completed

Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults

Healthy

United States
Inovio Pharmaceuticals

Completed

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Anal Neoplasm

United States, Canada
Invibio Ltd

Completed

Qualitative Interviews With Healthcare Professionals

Total Knee Replacement

United States
Inovio Pharmaceuticals

Terminated

Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma

Head and Neck Cancer

United States
Inovio Pharmaceuticals

Terminated

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

Head Neck Cancer

United States
Inovio Pharmaceuticals

Completed

Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects

Hepatitis B

Australia, Taiwan, United States, Singapore, New Zealand, Hong Kong, Thailand, Philippines
Inovio Pharmaceuticals

Completed

A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3 (HPV-003)

Cervical Intraepithelial Neoplasia

South Africa, United States, Korea, Republic of, Canada, Estonia, India, Georgia, Australia, Puerto Rico
Inovio Pharmaceuticals

Completed

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

Prostate Cancer

United States
Inovio Pharmaceuticals

Completed

Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer

Cancer

United States
Inovio Pharmaceuticals

Completed

A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001

Healthy

United States
Inovio Pharmaceuticals

Completed

A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus

Healthy

United States
Inovio Pharmaceuticals

Completed

Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants (HIV-001)

HIV Infections | HIV-1 Infection

United States
Invibio Ltd
In2Bones

Recruiting

A Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus

Hallux Rigidus

United States
Nobio Ltd.

Unknown

Nobio Antimicrobial Particles Effect in a Split Mouth Model

Cervical Caries

Israel
NKBio Co.Ltd.

Unknown

Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients (NKCell)

Diffuse Large B-cell Lymphoma

Korea, Republic of
Instituto Oncológico Dr Rosell
IN3BIO; PANGAEA

Unknown

Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge (COVINVAC)

Covid19 | Pulmonary Fibrosis

Spain
GeneOne Life Science, Inc.
International Vaccine Institute; Inovio Pharmaceuticals

Completed

Evaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy Volunteers

Healthy

Korea, Republic of
Malo Clinic
Invibio Ltd

Enrolling by invitation

PEEK Prostheses in the All-on-4 Concept Using Zygomatic Implants for Full-arch Rehabilitation. (PEEKPilotZyg)

Prosthesis Survival

Portugal
Malo Clinic
Invibio Ltd

Enrolling by invitation

Partial Rehabilitation Using a PEEK-acrylic Resin Removable Partial Denture (PEEKPilotRPD)

Prosthesis Survival

Portugal
Invibio Ltd
NGMedical GmbH

Recruiting

Study to Evaluate the Clinical and Radiographic Outcomes of the BEE® HA Cage for Anterior Cervical Discectomy and Fusion

Cervical Disc Degeneration

Germany
Malo Clinic
Invibio Ltd

Enrolling by invitation

Partial Implant-supported Rehabilitation Using PEEK (PEEKPilotSB)

Prosthesis Survival

Portugal
Malo Clinic
Invibio Ltd

Enrolling by invitation

Single Tooth Implant-supported Fixed Prosthetic Rehabilitation Using PEEK. (PEEKPilotST)

Prosthesis Survival

Portugal
Malo Clinic
Invibio Ltd

Active, not recruiting

Hybrid PEEK-Acrylic Resin Prostheses and the All-on-4 Concept for Full-Arch Rehabilitation - Routine Group (AO4PEEKRG)

Prosthesis Survival

Portugal
Tripep AB
Inovio Pharmaceuticals

Unknown

Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients

Chronic Hepatitis C Virus Infection

Sweden
University Potiguar
Federal University of São Paulo; InBios International, Inc.

Completed

Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy (Nanoparticle)

Menopausal Syndrome

Brazil
U.S. Army Medical Research and Development Command
InBios International, Inc.

Completed

Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis

Skin Diseases

United States

3

Subscribe